Molecular Diagnostics: Market Landscape This report analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests that are positioned in this exciting area of diagnostics. The current MDx market size and leading players are analyzed, with a market forecast of the MDx segment as well as the total in vitro diagnostic market over 2010-16 provided. Features and benefits
Full classification of the MDx sector and where it sits within the helathcare landscape. Detailed overview of both the US and EU regualtory landscapes with barriers to uptake introduced. Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/142543-molecular-diagnostics-marketlandscape.html
Highlights This module serves as a primer on the molecular diagnostics (MDx) sector, introducing Datamonitor’s classification of what MDx is and where it sits within the healthcare landscape. The module also details the regulatory and reimbursement considerations for MDx technologies and details a market forecast for this high-growth sector out to 2016. Major points covered in Table of Contents of this report include:
ABOUT DATAMONITIOR HEALTHCARE ABOUT THIS REPORT EXECUTIVE SUMMARY CLASSIFICATION OF MOLECULAR DIAGNOSTICS REGULATION AND REIMBURSEMENT OF MOLECULAR DIAGNOSTICS THE MOLECULAR DIAGNOSTICS MARKET APPENDIX List Of Table List Of Figures
Explore Table of Contents available in the report Molecular Diagnostics: Market Landscape.
Report Details: Published: November 2011 No. of Pages: 49 Price: Single User License – US$3800
Corporate User License – US$9500
Contact: Priyank Tiwari 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-391-5441 sales@reportsandreports.com Visit our Market Research Blog @ http://www.reportsnreportsblog.com/ Connect With Us: